{"id":33122,"date":"2025-03-21T19:25:39","date_gmt":"2025-03-21T18:25:39","guid":{"rendered":"https:\/\/jegharkraeft.dk\/?p=33122"},"modified":"2026-04-11T18:54:55","modified_gmt":"2026-04-11T17:54:55","slug":"low-dose-naltrexone","status":"publish","type":"post","link":"https:\/\/jegharkraeft.dk\/en\/low-dose-naltrexone\/","title":{"rendered":"LDN &#8211; Low dose Naltrexone and cancer"},"content":{"rendered":"\n<div class=\"wp-block-group alignfull is-style-section-5 has-contrast-color has-base-background-color has-text-color has-background has-link-color wp-elements-9fbc068f4af265ce16332509885fd091 has-global-padding is-layout-constrained wp-block-group-is-layout-constrained is-style-section-5--2\" id=\"menu\" style=\"margin-top:0;margin-bottom:0;padding-top:var(--wp--preset--spacing--50);padding-bottom:var(--wp--preset--spacing--50)\">\n<div class=\"wp-block-columns alignwide is-layout-flex wp-container-core-columns-is-layout-ca2dd60b wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<h2 class=\"wp-block-heading has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-85c9ab605a9af581478ba1bfba8fd611\"><span class=\"ez-toc-section\" id=\"Treatments\"><\/span><a href=\"https:\/\/jegharkraeft.dk\/en\/cancer-treatments-overview\/\">Treatments<\/a><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-52532d4beacf4a32227a79286a8276fc\"><span class=\"ez-toc-section\" id=\"Complementary_and_Alternative_Treatments\"><\/span><a href=\"https:\/\/jegharkraeft.dk\/en\/alternative-cancer-treatments-overview\/\">Complementary and Alternative Treatments<\/a><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<div class=\"wp-block-group has-custom-interne-links-color has-text-color has-link-color wp-elements-f0b533ba5ba162d83ba127a822fcb15b has-global-padding is-layout-constrained wp-block-group-is-layout-constrained\">\n<ol class=\"wp-block-list\">\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-77af1ff414b9d4332e6894d962b49b0a\"><a href=\"https:\/\/jegharkraeft.dk\/en\/akupunktur\/\">Physical treatments<\/a>\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-6e82d16ebb05a873d5add76b34d259ef\"><a href=\"https:\/\/jegharkraeft.dk\/en\/repurposed-drugs\/\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-hvid-tekst-color\">Repurposed Drugs &#8211; General<\/mark><\/a>\n<ol class=\"wp-block-list\">\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-780fac237d6d09f0087842050420bfba\"><a href=\"https:\/\/jegharkraeft.dk\/en\/aspirin\/\">Painkillers and anti-inflammatory drugs<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-fad7d0169f73487a5cb08247fb6344df\"><a href=\"https:\/\/jegharkraeft.dk\/en\/dipyridamole\/\">Heart and circulatory medications<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-110ab3157ece675d1aeb7921af0e506a\"><a href=\"https:\/\/jegharkraeft.dk\/en\/doxycycline\/\">Antibiotics and antiparasitic agents<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-a99575c8ffb4e827783ab6d56f16ed45\"><a href=\"https:\/\/jegharkraeft.dk\/en\/metformin\/\">Diabetes medication<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-8d31961b581546503fd37288fbf45aba\"><a href=\"https:\/\/jegharkraeft.dk\/en\/low-dose-naltrexone\/\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-hvid-tekst-color\">Agents affecting hormones and signaling substances<\/mark><\/a>\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-her-st-r-du-color has-text-color has-link-color wp-elements-29857eed7feb0e1cadae8c935bdd6318\"><a href=\"#low-dose-naltrexone\">LDN (Low Dose Naltrexone) (scroll down)<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/jegharkraeft.dk\/en\/melatonin\/\">Melatonin<\/a><\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-dd7ca0bc23a9ec3ca6e860ef8de7693a\"><a href=\"https:\/\/jegharkraeft.dk\/en\/disulfiram\/\">Other medications<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-66a0e4204f5201bcc8494f5822b38efe\"><a href=\"https:\/\/jegharkraeft.dk\/en\/the-coc-protocol\/\">COC Protocol<\/a><\/li>\n<\/ol>\n<\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-9504e56e950d068c15963cbdbf1fdaaf\"><a href=\"https:\/\/jegharkraeft.dk\/en\/no-medicine-plan-b\/\">No medication \u2013 Plan B<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-50bb8d7b4bb216418ba3c0d4a402648c\"><a href=\"https:\/\/jegharkraeft.dk\/en\/repurposed-drugs-and-chemotherapy\/\">Repurposed drugs and chemotherapy<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-af88e7f595afd58f141d2c174a141555\"><a href=\"https:\/\/jegharkraeft.dk\/en\/repurposed-drugs-and-radiotherapy\/\">Repurposed drugs and radiation therapy<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-7098df34ebce445cd1790d85e10991eb\"><a href=\"https:\/\/jegharkraeft.dk\/en\/flcccs-ranking\/\">FLCCC\u2019s ranking of repurposed drugs<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-4c827eb85783b3d07583409effc04d57\"><a href=\"https:\/\/jegharkraeft.dk\/en\/brain-metastases-and-bloodbrain-barrier\/\">Brain metastases and the blood-brain barrier<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-cf6cfac91ed1b7d193bc5d25a711b818\"><a href=\"https:\/\/jegharkraeft.dk\/en\/bombs-fire-extinguishers-and-timing\/\">Bombs, fire extinguishers, and timing<\/a><\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:50%\">\n<figure class=\"wp-block-image aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"741\" height=\"741\" src=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/02\/bLDN_piller.red_.jpeg\" alt=\"LDN - Low Dose Naltrexone hydrochlorid her i lille b\u00f8tte, magistralt fremstillet fra apotek i Danmark.\" class=\"wp-image-33121\" style=\"aspect-ratio:3\/2;object-fit:cover;width:550px\" srcset=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/02\/bLDN_piller.red_.jpeg 741w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/02\/bLDN_piller.red_-300x300.jpeg 300w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/02\/bLDN_piller.red_-100x100.jpeg 100w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/02\/bLDN_piller.red_-600x600.jpeg 600w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/02\/bLDN_piller.red_-150x150.jpeg 150w\" sizes=\"auto, (max-width: 741px) 100vw, 741px\" \/><\/figure>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-group alignfull is-style-default has-global-padding is-layout-constrained wp-container-core-group-is-layout-b040ace0 wp-block-group-is-layout-constrained has-background\" style=\"margin-top:0;margin-bottom:0;padding-top:var(--wp--preset--spacing--60);padding-right:var(--wp--preset--spacing--20);padding-bottom:var(--wp--preset--spacing--60);padding-left:var(--wp--preset--spacing--20);background-image:url(&apos;https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/02\/bLDN_piller.red_.jpeg&apos;);background-position:44% 36%;background-size:cover;\">\n<div class=\"gb-element-906497af\">\n<h1 class=\"wp-block-heading\" id=\"low-dose-naltrexone\"><span class=\"ez-toc-section\" id=\"LDN_Low_dose_Naltraxone_and_cancer\"><\/span>LDN (Low dose Naltraxone) and cancer<span class=\"ez-toc-section-end\"><\/span><\/h1>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_is_LDN\"><\/span>What is LDN<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Naltrexone is a drug originally approved for the treatment of alcohol and heroin addiction. Here, it is typically used in doses of 60 mg or higher. LDN (Low-Dose Naltrexone) is an interesting treatment that has gained attention in alternative medicine in recent years. Although primarily used for treating chronic pain and certain autoimmune diseases, there have also been studies looking at its potential role in cancer treatment.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_is_low_dose\"><\/span>What is low dose<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">When speaking of low dose, this is typically between 2\u201310 mg, most often 4.5 mg daily. It is now used in connection with pain management but has, in certain contexts, proven effective for the prevention or treatment of cancer. Although not approved by pharmaceutical authorities for this purpose, LDN&#8217;s potential in cancer treatment is being investigated in a number of clinical trials and has so far shown promising results in some studies.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"LDNs_effect_against_cancer\"><\/span>LDN&#8217;s effect against cancer<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Although the precise mechanism behind LDN&#8217;s action is not fully understood, it is believed to act on cancer in several different ways:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Antioxidant effect<\/strong>: <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>LDN can protect cells from damage by free radicals that can contribute to cancer.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Immunomodulation<\/strong>: <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>LDN can affect immune system activity and strengthen the body&#8217;s own ability to fight disease. LDN can thus strengthen the immune system and thereby help the body fight cancer cells.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Anti-inflammatory effect<\/strong>: <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Chronic inflammation is associated with cancer development. LDN&#8217;s anti-inflammatory effect can contribute to reducing cancer risk.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Interacting with opioid receptors<\/strong>: <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Naltrexone was originally developed as an opioid receptor antagonist, but in low doses, it may have a different mechanism of action.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Hormonal regulation<\/strong>: <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>LDN can affect hormones that play a role in cancer development, e.g., growth hormones.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Side_effects_of_LDN\"><\/span>Side effects of LDN<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">LDN is generally well-tolerated in low doses but can cause side effects such as:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Nausea and vomiting<\/li>\n\n\n\n<li>Headache<\/li>\n\n\n\n<li>Dizziness<\/li>\n\n\n\n<li>Sleep problems<\/li>\n\n\n\n<li>Vivid dreams<\/li>\n\n\n\n<li>Skin itching<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">In rare cases, LDN can have more serious side effects, such as liver damage. LDN is (as is also the case for other repurposed drugs for cancer) not approved by pharmaceutical authorities for cancer treatment.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Note\"><\/span>Note<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">It should be noted that this is not an exhaustive list of all possible side effects. You can find more information about side effects in the package leaflet for your medication. It is important to talk to your doctor about potential risks and side effects before you start taking LDN. Furthermore, be aware that certain medications can interact, so unintended effects may occur when these are combined. If in doubt, it can be checked here:<\/p>\n\n\n\n<p class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b7e7dfec0593ccd269584eaf690c1487 wp-block-paragraph\"><a rel=\"noreferrer noopener\" href=\"https:\/\/www.drugs.com\/?fbclid=IwZXh0bgNhZW0CMTAAAR2Un76TmB0Yk4p7gHQ4TUFL7cCg_ob3aVB1DcZjT48o-YwFap8riMvnNiQ_aem__ZDuOwAdzVO0yZi5iJKihQ\" target=\"_blank\"><strong>Drugs.com<\/strong><\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Research\"><\/span>Research<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Research into LDN and cancer is still in its early stages, and more comprehensive studies are needed to confirm the preliminary results. Preliminary clinical trials have shown that LDN can:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Extend survival in patients with advanced lung cancer.<\/li>\n\n\n\n<li>Reduce the risk of recurrence in patients with breast cancer.<\/li>\n\n\n\n<li>Improve the response to chemotherapy and radiation therapy in cancer patients.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">However, it is important to note that these studies have had limitations, such as small patient sizes and a lack of control groups. There is also a need for more research to understand the precise mechanisms behind LDN&#8217;s potential effect against cancer. Research into LDN and cancer is still in its early stages, and more comprehensive studies are needed.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span>Conclusion<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Low-Dose Naltrexone (LDN) is a drug originally developed for the treatment of addiction but is now being investigated for its potential in cancer treatment. It is believed to strengthen the immune system, reduce inflammation, and interact with hormones, which may contribute to fighting cancer. Although LDN shows promising results, including prolonged survival in patients with advanced lung cancer and a reduced risk of recurrence in breast cancer patients, research is still in its early phases, and more comprehensive studies are needed to confirm these effects. Side effects are generally mild, but it is necessary to discuss them with a doctor, especially since it is prescription medication. Further research will be crucial to understanding LDN&#8217;s role and safety in cancer treatment.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">See also <a href=\"https:\/\/jegharkraeft.dk\/en\/repurposed-drugs\/\">Repurposed Drugs<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">See also <a href=\"https:\/\/jegharkraeft.dk\/en\/no-medicine-plan-b-2\/\">No medicine &#8211; Plan B<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">See also <a href=\"https:\/\/jegharkraeft.dk\/en\/metabolic-strategi\/#ldn\">Link-overview<\/a><\/p>\n\n\n\n<p class=\"has-custom-menu-links-color has-text-color has-link-color wp-elements-ef7d07e4a2f3fd4865240f3b1020f6b6 wp-block-paragraph\"><a href=\"#menu\">(to menu)<\/a><a href=\"https:\/\/jegharkraeft.dk\/en\/repurposed-drugs\/\"><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Links<\/h4>\n\n\n\n<p class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-8f64470dbd6f70331b017b0d6414476f wp-block-paragraph\"><a href=\"https:\/\/www.interaktionsdatabasen.dk\/\" target=\"_blank\" rel=\"noreferrer noopener\">Interaktioner <\/a>(search for preparations) (Interaktionsdatabasen, Danish Medicines Agency) (Danish Language)<\/p>\n\n\n\n<p class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-281d42d9ca912ebd3ea686f9c0cf6d4e wp-block-paragraph\"><a href=\"https:\/\/www.ldnforeningen.dk\/\" target=\"_blank\" rel=\"noreferrer noopener\">LDN \u2013 Lav Dosis Naltrexone<\/a> (LDN Foreningen) (Danish Language)<\/p>\n\n\n\n<p class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-24a11f5941acd95d33c52876226df2f2 wp-block-paragraph\"><a href=\"https:\/\/www.horstedinstitute.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">Tina Horsted<\/a> (Doctors Website) (Danish Language)<\/p>\n\n\n\n<p class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-8a2e4c01445798ade70fae49a82175a0 wp-block-paragraph\"><a href=\"https:\/\/www.horstedinstitute.com\/\" target=\"_blank\" rel=\"noopener\">Specialist in Anesthesia and Pain Management<\/a> (Horsted Institute) (Danish Language)<\/p>\n\n\n\n<p class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-15cfbdeb7181ef8927c5f1185d36ad6b wp-block-paragraph\"><a href=\"https:\/\/www.xn--klinikslotssen-1qb.dk\/2022\/05\/23\/kan-ldn-modvirke-udviklingen-af-kraeft\/\" target=\"_blank\" rel=\"noopener\">Can LDN counteract the development of cancer? <\/a>(Klinik Slotss\u00f8en) (Danish Language)<\/p>\n\n\n\n<p class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-e0a062bd9c38a0593ccac9718c49462c wp-block-paragraph\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33337537\/\" target=\"_blank\" rel=\"noreferrer noopener\">Naltrexone&#8217;s Impact on Cancer Progression and Mortality: A Systematic Review of Studies in Humans, Animal Models, and Cell Cultures<\/a> (PubMed)<\/p>\n\n\n\n<p class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-502aba23696fe8c43ca6aa172d5d890f wp-block-paragraph\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC10968813\/\" target=\"_blank\" rel=\"noreferrer noopener\">Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy<\/a> (Cancers, 2024)<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Content<\/strong>: A new review article explaining the primary hypothesis in detail: LDN temporarily blocks the body&#8217;s Opioid Growth Factor receptor (OGFr), causing the body to compensate by producing more endorphins and enkephalins. These act as immunomodulators. This is a non-randomized systematic review.<\/li>\n<\/ul>\n\n\n\n<p class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-522c8124fafc92446ab2d6190a2f1c2e wp-block-paragraph\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21807817\/\" target=\"_blank\" rel=\"noopener\">Low-Dose Naltrexone Targets the Opioid Growth Factor Receptor to Inhibit Cell Proliferation in Triple-Negative Breast Cancer<\/a> (PubMed, 2011)<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-cfbfcff0da0b852096afd764d54b803f\"><strong>Content<\/strong>: This article demonstrates how LDN inhibits triple-negative breast cancer via OGFr blockade and immunomodulation, directly relating to the primary hypothesis. It explains the mechanisms of cellular growth inhibition in detail. This is a non-randomized preclinical laboratory study.<\/li>\n<\/ul>\n\n\n\n<p class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c36c7fe9e2b32971840bf9143368d06c wp-block-paragraph\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38539570\/\" target=\"_blank\" rel=\"noopener\">Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy<\/a> (PubMed, 2025)<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Content<\/strong>: Low-dose naltrexone blocks the OGFr receptor, increasing OGF synthesis which inhibits cancer development. Studies show LDN can help inactivate cancer cell growth without being directly cytotoxic, serving as a supplement. This is a non-randomized review and protocol for cancer treatment.<\/li>\n<\/ul>\n\n\n\n<p class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-37efd1fde909cb7961a914af11e15bfd wp-block-paragraph\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29885638\/\" target=\"_blank\" rel=\"noopener\">Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy<\/a> (PubMed, 2018)<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Content<\/strong>: The article reviews how low-dose naltrexone can function as an immunomodulator in autoimmune diseases and cancer. Research shows LDN binds to opioid receptors on immune cells, potentially regulating the body&#8217;s immune response. This is a non-randomized review of clinical and basic research.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Page created:<\/strong> July 1, 2024, Last revised February 23, 2026<\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">\u2764<\/mark><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><em>What you read on Jeg har Kr\u00e6ft is not a recommendation. Seek competent guidance.<\/em><\/strong><\/p>\n<\/div>\n<\/div>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_86 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Indhold<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><ul class='ez-toc-list-level-2' ><li class='ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/jegharkraeft.dk\/en\/low-dose-naltrexone\/#Treatments\" >Treatments<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/jegharkraeft.dk\/en\/low-dose-naltrexone\/#Complementary_and_Alternative_Treatments\" >Complementary and Alternative Treatments<\/a><\/li><\/ul><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-1'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/jegharkraeft.dk\/en\/low-dose-naltrexone\/#LDN_Low_dose_Naltraxone_and_cancer\" >LDN (Low dose Naltraxone) and cancer<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/jegharkraeft.dk\/en\/low-dose-naltrexone\/#What_is_LDN\" >What is LDN<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/jegharkraeft.dk\/en\/low-dose-naltrexone\/#What_is_low_dose\" >What is low dose<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/jegharkraeft.dk\/en\/low-dose-naltrexone\/#LDNs_effect_against_cancer\" >LDN&#8217;s effect against cancer<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/jegharkraeft.dk\/en\/low-dose-naltrexone\/#Side_effects_of_LDN\" >Side effects of LDN<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/jegharkraeft.dk\/en\/low-dose-naltrexone\/#Note\" >Note<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/jegharkraeft.dk\/en\/low-dose-naltrexone\/#Research\" >Research<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/jegharkraeft.dk\/en\/low-dose-naltrexone\/#Conclusion\" >Conclusion<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Treatments Complementary and Alternative Treatments LDN (Low dose Naltraxone) and cancer What is LDN Naltrexone is a drug originally approved for the treatment of alcohol and heroin addiction. Here, it is typically used in doses of 60 mg or higher. LDN (Low-Dose Naltrexone) is an interesting treatment that has gained attention in alternative medicine in [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":33121,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[393,375,374,396],"tags":[],"class_list":["post-33122","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-repurposed-drugs","category-alternative-treatments","category-treatments","category-immunomodulatory-agents"],"modified_by":"Hanne Kj\u00e6r Uhlig","wpml_current_locale":"en_US","wpml_translations":[],"_links":{"self":[{"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/posts\/33122","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/comments?post=33122"}],"version-history":[{"count":1,"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/posts\/33122\/revisions"}],"predecessor-version":[{"id":33827,"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/posts\/33122\/revisions\/33827"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/media\/33121"}],"wp:attachment":[{"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/media?parent=33122"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/categories?post=33122"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/tags?post=33122"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}